Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1)

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 713-722

  McVey, Douglas C ^a,b   Schmid, Patricia C ^a,b   Schmid, Harald H O ^a,b   Vigna, Steven R ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; CLOSTRIDIUM TOXIN; DEXANABINOL; FATTY ACID AMIDASE; RIMONABANT; SUBSTANCE P; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM DIFFICILE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME DEGRADATION; ILEITIS; ILEUM; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RECEPTOR BINDING; SENSORY NERVE CELL; STATISTICAL SIGNIFICANCE; TOXIN ANALYSIS;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; FATTY ACIDS, UNSATURATED; ILEITIS; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; SUBSTANCE P;

EID: 0037308120     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.043893     Document Type: Article

References (44)

1. Anovi-Goffer S, McKay NG, Ashford MLJ, and Coutts AA (2002) Vanilloid receptor type 1-immunoreactivity is expressed by intrinsic afferent neurones in the guineapig myenteric plexus. Neurosci Lett 319:53-57.
2. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466-468.
3. Beaulieu P, Bisogno T, Punwar S, Farquhar-Smith WP, Ambrosino G, DiMarzo V, and Rice ASC (2000) Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 396:85-92.
4. Bradley PP, Priebat DA, Christensen RD, and Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209.
5. Castagliuolo I, Keates AC, Qiu B, Kelly CP, Nikulasson S, Leeman SE, and Pothoulakis C (1997) Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 94:4788-4793.
6. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, and Pothoulakis C (1994) Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107:657-665.
7. Castagliuolo I, Riegler M, Pasha A, Nikulasson S, Lu B, Gerard C, and Gerard NP (1998) Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J Clin Investig 101:1547-1550.
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
9. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, and Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371-9376.
10. Deutsch DG, Ueda N, and Yamamoto S (2002) The fatty acid amide hydrolase (FAAH). Prostoglandins Leukotrienes Essent Fatty Acids 66:201-210.
11. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
12. Dickenson AH and Dray A (1991) Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception. Br J Pharmacol 104:1045-1049.
13. Herkenham M (1995) Localization of cannabinoid receptors in brain and periphery, in Cannabinoid Receptors (Pertwee RG ed) pp 146-166, Academic Press, London.
14. 1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134:563-570.
15. Izzo AA, Mascolo N, Pinto L, Capasso R, and Capasso F (1999) The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur J Pharmacol 384:37-42.
16. 3 tachykinin receptors in neurons of the rat myenteric plexus. Neuroscience 100:191-199.
17. Karlsson K, Contreras JA, Hellman U, Tornqvist H, and Holm C (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyeeride lipase. Evolutionary relationship to esterases, lysophospholipases and haloperoxidases. J Biol Chem 272:27218-27223.
18. Katayama K, Ueda N, Kurahashi Y, Suzuki H, Yamamoto S, and Kato I (1997) Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochim Biophys Acta 1347:212-218.
19. 1 cannabinoid receptors. Br J Pharmacol 134:161-167.
20. Mann PT, Southwell BR, and Furness JB (1999) Internalization of the neurokinin 1 receptor in rat myenteric neurons. Neuroscience 91:353-362.
21. Mantyh CR, Pappas TN, Lapp JA, Washington MK, Neville LM, Ghilardi JR, Rogers SD, Mantyh PW, and Vigna SR (1996) Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 111:1272-1280.
22. Mantyh PW, Demaster E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE, et al. (1995) Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science (Wash DC) 268:1629-1632.
23. 9-tetrahydrocannabinolinduced inhibition of natural killer activity. Eur J Pharmacol 387:343-347.
24. McVey DC and Vigna SR (2001) The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides 22:1439-1446.
25. Mechoulam R, Ben-Shabat S, Hanuš L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
26. Mechoulam R, Fride E, and DiMarzo V (1998) Endocannabinoids. Eur J Pharmacol 359:1-18.
27. Perkins MN and Campbell EA (1992) Capsazepine reversal of the antinociceptive action of capsaicin in vivo. Br J Pharmacol 107:329-333.
28. Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR, Mascolo N, Di Marzo V, and Capasso F (2002) Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123:227-234.
29. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, and Leeman SE (1994) CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile to A but not cholera toxin. Proc Natl Acad Sci USA 91:947-951.
30. 1 receptors. Pain 75:111-119.
31. Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, DiMarzo V, and Pertwee RG (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide and certain of its analogues at vanilloid receptors in transfected cells and vas deferans. Br J Pharmacol 132:631-640.
32. 1) antagonists. Trends Pharmacol Sci 20:485-490.
33. Schmid PC, Schwartz KD, Smith CN, Krebsbach RJ, Berdyshev EV, and Schmid HHO (2000) A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoglycerols. Chem Phys Lipids 104:185-191.
34. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, and Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
35. Southwell BR, Seybold VS, Woodman HL, Jenkinson KM, and Furness JB (1998a) Quantitation of neurokinin 1 receptor internalization and recycling in guinea-pig myenteric neurons. Neuroscience 87:925-931.
36. Southwell BR, Woodman HL, Murphy R, Royal SJ, and Furness JB (1996) Characterisation of substance P-induced endocytosis of NK1 receptors on enteric neurons. Histochem Cell Biol 106:563-571.
37. Southwell BR, Woodman HL, Royal SJ, and Furness JB (1998b) Movement of villi induces endocytosis of NK1 receptors in myenteric neurons from guinea-pig ileum. Cell Tissue Res 292:37-45.
38. Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, McClung J, Shebani K, Moore F, O'Brien M, and Becker JM (2000) NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol 279:G1298-G1306.
39. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
40. Szallasi A and DiMarzo V (2000) New perspectives on enigmatic vanilloid receptors. Trends Neurosci 23:491-497.
41. Torres J, Jennische E, Lange S, and Lönnroth I (1990) Enterotoxins from Clostridium difficile: diarrhoeogenic potency and morphological effects in the rat intestine. Gut 31:781-785.
42. Vigna SR, Bowden JJ, McDonald DM, Fisher J, Okamoto A, McVey DC, Payan DG, and Bunnett NW (1994) Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J Neurosci 14:834-845.
43. Yiangou Y, Facer P, Dyer NHC, Chan CLH, Knowles C, Williams NS, and Anand P (2001) Vanilloid receptor I immunoreactivity in inflamed human bowel. Lancet 357:1338-1339.
44. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Di Marzo V, Julius D, and Högestätt D (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.